无溶剂、无催化剂条件下α-腺嘌呤阿拉伯糖苷的合成

为了发展有效合成α-腺嘌呤阿拉伯糖苷的方法,以1,2,3,5-四-O-乙酰基-β-D-阿拉伯糖和6-氯嘌呤为原料,在微波辐射和无溶剂、无催化剂条件下反应得到中间体9-α-D-(2',3',5'-三-O-乙酰基)阿拉伯呋喃糖基-6-氯嘌呤,收率85%。该中间体物在Na2CO3催化下脱除乙酰基,然后"一锅"加入饱和的NH3/CH3OH溶液氨解,以90%的收率得到α-腺嘌呤阿拉伯糖苷。关键中间体9-α-D-(2',3',5'-三-O-乙酰基)阿拉伯呋喃糖基-6-氯嘌呤的合成反应规模可以扩大到100 g。类似地合成α-2-氟腺嘌呤阿拉伯糖苷和α-2-氨基腺嘌呤阿拉伯糖苷。     

新多取代吡啶类化合物的合成及生物活性

为寻找具有农用生物活性的新颖化合物,以2-氰基硫代乙酰胺为起始原料经由三步反应,设计并合成出了一系列新颖的多取代吡啶衍生物2-甲基-5-氰基-6-炔丙硫基-4-(2-呋喃基或噻吩基)吡啶-3-甲酸甲酯或乙酯和6-甲基-5-乙酰基-2-炔丙硫基-4-(2-呋喃或噻吩基)吡啶-3-乙腈.所有新化合物均经过1H NMR和元素分析确证.初步生物活性测定表明:化合物7有一定的除草和杀菌活性.     

几种多取代吡咯的NMR研究(Ⅰ)

本文测定了1-笨基-2-甲基-3-乙酰基-5-对氯苯基吡咯(I)等十个多取代吮咯的¹HNMR谱和其中五个化合物的¹³CNMR谱。归属了共振谱线,证实了各化合物的分子结构。得到了2-甲基-3-乙酰基-5-对氯苯基吡咯基-1在苯衍生物中的经验取代基增量。     

2-氨基-3-羟基环戊烯-1-腈衍生物的合成和晶体结构

用低价钛试剂(TiCl~4-Zn)与α,α-(4-氯苯基)(二氰甲基)甲基苯基酮反应合成了非对映消旋体(3R,5S;3S,5R)和(3R,5R;3S,5S)2-氨基-3-羟基-3-苯基-5-对氯苯基环戊烯-1-腈。并用X射线衍射分析确定了这两个非对映异构体的构型。     

无催化剂条件下4-羟基烷基-2-炔酸乙酯与N-杂环芳基甲基-N-2,2-二氟乙基-1-胺的串联反应

开发了无催化剂条件下4-羟基烷基-2-炔酸乙酯与N-杂环芳基甲基-N-2,2-二氟乙基-1-胺的串联反应.应用该反应在甲醇中回流,以39%~83%的收率合成了一系列4-(N-(2,2-二氟乙基)(N-杂环芳基甲基)氨基)-5,5-二取代呋喃-2(5H)-酮,其结构经1H NMR,13C NMR和HR-ESI-MS表征,并进一步通过3-氯-4-(N-2,2-二氟乙基)(N-嘧啶-5-基甲基胺基)-5,5-螺(4-甲氧基环己基)呋喃-2(5H)-酮(8)的晶体衍射间接证实.测试了所合成化合物的生物活性,结果表明,在600μg·mL^-1浓度时4-(N-2,2-二氟乙基)(N-6-氯吡啶-3-基甲基胺基)-5,5-二甲基呋喃-2(5H)-酮(3a)和4-(N-2,2-二.氟乙基)(N-6-氟吡啶-3-基甲基胺基)-5,5-二甲基呋喃-2(5H)-酮(3c)对桃蚜的死亡率均为100%.     

无催化剂条件下4-羟基烷基-2-炔酸乙酯与N-杂环芳基甲基-N-2,2-二氟乙基-1-胺的串联反应（英文）

开发了无催化剂条件下4-羟基烷基-2-炔酸乙酯与N-杂环芳基甲基-N-2,2-二氟乙基-1-胺的串联反应.应用该反应在甲醇中回流,以39%～83%的收率合成了一系列4-(N-(2,2-二氟乙基)(N-杂环芳基甲基)氨基)-5,5-二取代呋喃-2(5H)-酮,其结构经~1H NMR, ~(13)C NMR和HR-ESI-MS表征,并进一步通过3-氯-4-((N-2,2-二氟乙基)(N-嘧啶-5-基甲基胺基)-5,5-螺(4-甲氧基环己基)呋喃-2(5H)-酮(8)的晶体衍射间接证实.测试了所合成化合物的生物活性,结果表明,在600μg·mL~(-1)浓度时4-((N-2,2-二氟乙基)(N-6-氯吡啶-3-基甲基胺基)-5,5-二甲基呋喃-2(5H)-酮(3a)和4-((N-2,2-二氟乙基)(N-6-氟吡啶-3-基甲基胺基)-5,5-二甲基呋喃-2(5H)-酮(3c)对桃蚜的死亡率均为100%.     

膦、胂叶立德的化学与应用ⅩⅩⅥ.含全氟烷基胂叶立德的合成及水解反应研究

报道溴化(α-呋喃甲酰基)甲基三苯基钟(1)在无水碳酸钾存在下,以无水二氯甲烷作溶剂,保持0～5℃下与2-全氟炔酸甲酯(2)反应,高产率地得到加合产物4-(α-呋喃甲酰基)-2-三苯基胂基-3-全氟烷基-3-丁烯酸甲酯(3).加合产物3在V(甲醇):V(水)=9:1溶液中分别于室温、回流和封管120℃三种条件下反应,高产率地得到4-全氟烷基-6-(α-呋喃基)-2-吡喃酮(4)和4-(α-呋喃甲酰基)-3-全氟烷基-3-丁烯酸甲酯(5).化合物4和5可以通过柱层析分离;化合物5为一对Z,E异构体,它们不能通过柱层析分离,但其比例可以由1HNMR估算得到.研究还发现硅胶对该反应具有催化作用,提出并讨论了反应机理.     

N6-烷基-2-烷氧基腺苷化合物的合成及抗血小板凝集活性

以鸟瞟呤核苷(1)为原料,经羟基保护得到2’,3’,5’-三-O-乙酰基鸟嘌呤核苷(2),2与三氯氧磷反应得到2-氨基-6-氯-9-(2’,3’,5’-三-O-乙酰基-β-D-呋喃核糖)嘌呤(3),3经重氮化、水解和O-烷基化得到2-烷氧基-6-氯-9-(2’,3’,5’-三-O-乙酰基-β-D-呋喃核糖)嘌呤(4a～...     

新型呋喃α-丁烯内酯类化合物的设计、合成及其生物活性研究

近年来,新烟碱杀虫剂的广泛使用不但导致害虫对其抗性逐渐增强,而且其对蜜蜂的毒性影响也越来越受到关注,因此设计合成生态友好型的新烟碱杀虫剂替代品显得迫在眉睫.实验室前期以低蜂毒杀虫剂氟吡呋喃酮的丁烯内酯为骨架,基于骨架相似性搜索发现,新型呋喃α-丁烯内酯骨架具有一定杀蚜活性.基于烟碱乙酰胆碱受体蛋白特征融合经验方法,设计并合成了一系列新型呋喃α-丁烯内酯类化合物.在500μg/m L浓度下对目标化合物进行大豆蚜和桃蚜的杀虫活性测试,结果表明该系列化合物对大豆蚜和桃蚜均表现一定的致死活性,其中(E)-3-((5-(3-氯苯基)呋喃-2-基)亚甲基)-5-甲基呋喃-2(3H)-酮(7bh)和(E)-3-((5-乙基呋喃-2-基)亚甲基)-5-(对甲苯基)呋喃-2(3H)-酮(7ch)对大豆蚜和桃蚜的致死率均达到70%以上,并且7bh对大豆蚜(LC₅₀=70.83μg/mL)和桃蚜(LC₅₀=71.96μg/mL)的杀虫活性与吡蚜酮在同一个数量级.意外发现该类化合物在50μg/m L浓度下对水稻纹枯病菌也表现出一定的离体抑菌活性.分子对接研究推测可能...     

胺基葡萄吡喃糖的含磷衍生物的合成及其抗肿瘤活性

本文利用氨基葡萄糖与芳香醛反应形成的亚胺和亚磷酸酯的P-H基团进行加成,合成了九个新型含一个具有两种构型的手性碳原子的N-[(对甲(氧)苯基)(O,O-二烷基膦酸酯基)甲基]-2-胺基-2-脱氧-1,3,4,6-四-O-乙酰基-βD-葡萄吡喃糖5。通过化合物5的醇解得到八个N-[对甲(氧)苯基)(O,O-二烷基膦酸酯基)甲基]-2-胺基-2-脱氧-D-葡萄吡喃糖6。~1H NMR和~(31)P NMR谱表明,化合物5由两个非对映异构体组成。用重结晶的方法,分离得到了两个单一构型的异构体5d′和5i′。通过X射线衍射分析,确定了异构体5i′的分子结构和绝对构型。初步抗肿瘤活性实验结果表明,化合物6对L_(1210)细胞和S-180腹水癌有一定的抑制作用。     

Reactions of stabilizer compounds. III. Oxidative reactions of some 2′-hydroxy-2-phenylbenzotriazole light stabilizers in the AIBN-initiated autoxidation of cumene

Oxidative decay of number of commercially important 2′-hydroxy-2-phenylbenzotriazole light stabilizers during the AIBN-initiated autoxidation of cumene at 65°C is described. The reactivity of the hydroxyphenylbenzotriazoles studied increased in the order 2-(2′-hydroxy-5′-methyl)phenylbenzotriazole (Ia) < 2-(2′-hydroxy-3′,5′ -di-tert-pentyl)phenylbenzotriazole (Ie) < 5-chloro-2-(3′,5′-di-tert-butyl-2′-hydroxy)phenylbenzotriazole (Ic) < 5-chloro-2-(3′-tert-butyl-2′-hydroxy-5′-methyl)phenylbenzotriazole (Ib). The major product from the reaction of Ib was identified as the cumylperoxycyclohexa-2,5-dienone (III). The possible occurrence of these reactions during the degradation of stabilized polymers is discussed.     

Synthesis and properties of 5-(1,2-dihaloethyl)-2′-deoxyuridines and related analogues

The regiospecific reaction of 5-vinyl-3′,5′-di-O-acetyl-2′-deoxyuridine ( 2 ) with HOX (X = Cl, Br, I) yielded the corresponding 5-(1-hydroxy-2-haloethyl)-3′,5′-di-O-acetyl-2′-deoxyuridines 3a-c . Alternatively, reaction of 2 with iodine monochloride in aqueous acetonitrile also afforded 5-(1-hydroxy-2-iodoethyl)-3′,5′-di-O-acetyl-2′-deoxyuridine ( 3c ). Treatment of 5-(1-hydroxy-2-chloroethyl)- ( 3a ) and 5-(1-hydroxy-2-bromoethyl)-3′,5′-di-O-acetyl-2′-deoxyuridine ( 3b ) with DAST (Et₂NSF₃) in methylene chloride at -40° gave the respective 5-(1-fluoro-2-chloroethyl)- ( 6a , 74%) and 5-(1-fluoro-2-bromoethyl)-3′,5′-di-O-acetyl-2′-deoxyuridine ( 6b , 65%). In contrast, 5-(1-fluoro-2-iodoethyl)-3′,5′-di-O-acetyl-2′-deoxyuridine ( 6e ) could not be isolated due to its facile reaction with methanol, ethanol or water to yield the corresponding 5-(1-methoxy-2-iodoethyl)- ( 6c ), 5-(1-ethoxy-2-iodoethyl)- ( 6d ) and 5-(1-hydroxy-2-iodoethyl)-3′,5′-di-O-acetyl-2′-deoxyuridine ( 3c ). Treatment of 5-(1-hydroxy-2-chloroethyl)- ( 3a ) and 5-(1-hydroxy-2-bromoethyl)-3′,5′-di-O-acetyl-2′-deoxyuridine ( 3b ) with thionyl chloride yielded the respective 5-(1,2-dichloroethyl)- ( 6f , 85%) and 5-(1-chloro-2-bromoethyl)-3′,5′-di-O-acetyl-2′-deoxyuridine ( 6g , 50%), whereas a similar reaction employing the 5-(1-hydroxy-2-iodoethyl)- compound 3c afforded 5-(1-methoxy-2-iodoethyl)-3′,5′-di-O-acetyl-2′-deoxyuridine ( 6c ), possibly via the unstable 5-(1-chloro-2-iodoethyl)-3′,5′-di-O-acetyl-2′-deoxyuridine intermediate 6h . The 5-(1-bromo-2-chloroethyl)- ( 6i ) and 5-(1,2-dibromoethyl)-3′,5′-di-O-acetyl-2′-deoxyuridine ( 6j ) could not be isolated due to their facile conversion to the corresponding 5-(1-ethoxy-2-chloroethyl)- ( 6k ) and 5-(1-ethoxy-2-bromoethyl)-3′,5′-di-O-acetyl-2′-deoxyuridine ( 61 ). Reaction of 5-(1-hydroxy-2-bromoethyl)-3′,5′-di-O-acetyl-2′-deoxyuridine ( 3b ) with methanolic ammonia, to remove the 3′,5′-di-O-acetyl groups, gave 2,3-dihydro-3-hydroxy-5-(2′-deoxy-β-D-ribofuranosyl)-furano[2,3-d]pyrimidine-6(5H)-one ( 8 ). In contrast, a similar reaction of 5-(1-fluoro-2-chloroethyl)-3′,5′-di-O-acetyl-2′-deoxyuridine ( 6a ) yielded (E)-5-(2-chlorovinyl)-2′-deoxyuridine ( 1b , 23%) and 5-(2′-deoxy-β-D-ribofuranosyl)furano[2,3-d]pyrimidin-6(5H)-one ( 9 , 13%). The mechanisms of the substitution and elimination reactions observed for these 5-(1,2-dihaloethyl)-3′,5′-di-O-acetyl-2′-deoxyuridines are described.     

Sur l'orientation et les anomalies de l'acetylation des Bz-méthoxy nitro-2 benzofurannes

4-Methoxy-, 5-methoxy- and 7-methoxy-2-nitrobenzofurans have been acetylated via the Friedel-Crafts reaction under the same reaction conditions. 2-Nitrobenzofuran does not undergo acetylation while 6-methoxy-2-nitrobenzofuran only produces decomposition products. As a result of the positive acetylation reactions, 7-acetyl-4-methoxy-, 4-acetyl-5-methoxy- and 4-acetyl-7-methoxy-2-nitrobenzofuran have been prepared. As side products in the acetylation reactions, 4-methoxy-3-(4′-methoxy-2′-nitro-7′-benzofuranyl)-2,3-dihydrobenzofuran-2-one was isolated when 4-methoxy-2-nitrobenzofuran was the starting material and, likewise, when 5-methoxy-2-nitrobenzofuran was the starting material, 3-chloro-5-methoxy-2,3-dihydrobenzofuran-2-one was obtained. Furthermore, 5-methoxy-2-nitrobenzofuran participated in an unexpected chlorination leading to 4-chloro-5-methoxy-2-nitrobenzofuran.     

The reaction of 2-acetoacetamidopyridines with phosgene. A route to novel 3-Acetyl-2-chloro-4H-pyrido[ 1,2-a] pyrimidin-4-ones

2-(Acetoacetamido)pyridine, 1 , and its 5-methyl derivative, 2 , with phosgene, gave 3-acetyl-2-chloro-4H-pyrido[1,2-a]pyrimidin- 4 -one, 5 , and 3-acetyl-2-chloro-7-methyl-4H-pyrido[1,2-a]-pyrimidin-4-one, 6 , respectively. The structures of these compounds followed from their elemental analyses, and interpretations of their uv, ir, pmr, and X-ray spectra. An alternative route to 5 and 6 , which sought first to react 1 and 2 with methyl - and benzyl chloroformates, was unsuccessful, and led, instead, to elimination of the acetoacetyl group with concomitant formation of the carbamate derivatives, 10 and 11 .     

Synthesis of 4-methylfuro[3′,2′:5,6]benzofuro[3,2-c]pyridine

4-Methylfuro[3′,2′:5,6]benzofuro[3,2-c]pyridine ( 3 ) was synthetized from 2-acetylfuro[3,2-f]benzo[b]furan ( 4 ) or from 2-acetyl-5,6-dihydrofuro[3,2-f]benzo[b]furan ( 10 ). The key step involves a rearrangement-cyclization of azides 6 and 12 to form 4-methylfuro[3′,2′:5,6]benzofuro[3,2-c]pyridin-1(2H) one ( 7 ) and 8,9-dihydro-4-methylfuro[3′,2′:5,6]benzofuro[3,2c]pyridin-1(2H)-one ( 13 ). Introduction of an aminoalkyl chain on carbon 1 was effected by substitution of 1-chloro-4-methylfuro[3′,2′:5,6]benzofuro[3,2-c]pyridine ( 8 ).     

Synthesis and chemistry of some pyridazine nucleosides related to certain 5-substituted pyrimidine nucleosides

Condensation of 3,4-dichloro-6-[(trimethylsilyl)oxy] pyridazine ( 3 ) with 1-O-acetyl-2,3,5-tri-O-benzoyl-β- D -ribofuranose ( 4 ), by the stannic chloride catalyzed procedure, has furnished 3,4-dichloro-1-(2,3,5-tri-O-benzoyl-β- D -ribofuranosyl) pyridazin-6-one ( 5 ). Nucleophilic displacement of the chloro groups and removal of the benzoyl blocking groups from 5 has furnished 3-chloro-4-methoxy-, 3,4-dimethoxy-, 4-amino-3-chloro-, 3-chloro-4-methylamino-, 3-chloro-4-hydroxy-, and 4-hydroxy-3-methoxy-1-β- D -ribofuranosylpyridazin-6-one. An unusual reaction of 5 with dimethylamine is reported. Condensation of 4,5-dichloro-3-nitro-6-[(trimethylsilyl)oxy]pyridazine with 4 yielded 4,5-dichloro-3-nitro-1-(2,3,5-tri-O-benzoyl-β- D -ribofuranosyl)pyridazin-6-one ( 24 ). Nucleophilic displacement of the aromatic nitro groups from 24 is discussed. Condensation of 3 with 3,5-di-O-p-toluoyl 2-deoxy- D -erythro-pentofuranosyl chloride ( 28 ) afforded an α, β mixture of 2-deoxy nucleosides. The synthesis of certain 3-substituted pyridazine 2′-deoxy necleosides are reported.     

SYNTHESIS OF THE C-DISACCHARIDE α-C(1→3)-L-FUCOPYRANOSIDE OF N-ACETYLGALACTOSAMINE[1]

Radical C-glycosidation of racemic 5-exo-benzeneselenyl-6-endo-chloro-3-methylidene-7-oxabicyclo[2.2.1]heptan-2-one ((±)-2) with α-acetobromofucose (3) provided a mixture of α-C-fucosides that were reduced with NaBH₄ to give two diastereomeric alcohols that were separated readily. One of them ((?)-6) was converted into (?)-methyl 2-acetamido-4-O-acetyl-2,3-dideoxy-3-C-(3′,4′,5′-tri-O-acetyl-2′,6′-anhydro-1′,7′-dideoxy-α-L-glycero-D-galacto-heptitol-1′-C-yl)-α -D-galactopyranuronate ((?)-11) and then into (?)-methyl 2-acetamido-2,3-dideoxy-3-C-(2′,6′-anhydro-1′,7′-dideoxy-α-L-glycero-D-galacto-heptitol-1′-C-yl)-β -D-galactopyranoside ((?)-1), a new α-C(1→3)-L-fucopyranoside of N-acetylgalactosamine. Its ¹H NMR data shows that this C-disaccharide (α-L-Fucp-(1→3)CH₂-β-D-GalNAc-OMe) adopts a major conformation in solution similar to that expected for the corresponding O-linked disaccharide, i.e., with antiperiplanar σ(C-3′,C-2′) and σ(C-1′,C-3) bonds.     

Synthesis of some new 5-chloro-7-mercapto-1-methyl/phenyl-1,2,4-triazolo[4,5-b]pyrazin-2(1H)-ones and 5-chloro-3-thiopyrazin-2(1H)-one derivatives as possible antibacterial and antifungal agents

Several new 5-chloro-7-mercapto-1-methyl/phenyl-1,2,4-triazolo[4,5-6]pyrazin-2(1/H)-ones V and their disul-phides VI, 5-chloro-3-mercapto-2(1H)-pyrazinonones III, 5-chloro-3-(N-aryl-N-acetylthioureido)-1-methyl/-phenyl-2(1H)-pyrazinones VII, 5-chloro-1-methyl/phenyl-3-sulphonamido-2(1H)-pyrazinones X and chloro-2-methyl/phenyl-(3-methyl)-3-thio-2(1H)-pyrazinones XI were synthesized starting from 3,5-dichloro-1-methyl/phenylpyrazin-2(1H)-ones I. Fifteen of these compounds were screened for their antibacterial and antifungal activity against two bacteria B. subtilis and S. aureus, and two fungi A. niger and H. oryzae. A possible structure activity relationship is given.     

The mass spectrometry of four acyl derivatives of 2,2′-difurylmethane

Low resolution mass spectra and high resolution data for selected important peaks are presented and discussed for the following compounds: [(5-acetyl-2-furyl)-(2′-furyl)]methane (I), [(5-acetyl-2-furyl)-(5′-methyl-2′-furyl)]methane (II), [(5-formyl-2-furyl)-(2′-furyl)]methane (III) and [(5-formyl-2-furyl)-(5′-methyl-2′-furyl)]methane (IV). The fragmentation of II has been clarified by examining the mass spectrum of its d3-acetyl analog; the fragmentation of III and IV by examining the spectra of their carbonyl 13C-labeled analogs.